Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - New York Stock Exchange, Inc. - US07831C1036 - Common Stock - Currency: USD

61.68  +1.05 (+1.73%)

After market: 61.68 0 (0%)

Fundamental Rating

5

Taking everything into account, BRBR scores 5 out of 10 in our fundamental rating. BRBR was compared to 35 industry peers in the Personal Care Products industry. BRBR scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, BRBR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
BRBR had a positive operating cash flow in the past year.
In the past 5 years BRBR has always been profitable.
Each year in the past 5 years BRBR had a positive operating cash flow.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With an excellent Return On Assets value of 29.66%, BRBR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
BRBR has a better Return On Invested Capital (46.22%) than 97.14% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 16.32%.
The last Return On Invested Capital (46.22%) for BRBR is above the 3 year average (38.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 29.66%
ROE N/A
ROIC 46.22%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

With an excellent Profit Margin value of 12.82%, BRBR belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
BRBR's Profit Margin has declined in the last couple of years.
BRBR has a better Operating Margin (19.80%) than 94.29% of its industry peers.
BRBR's Operating Margin has been stable in the last couple of years.
BRBR has a worse Gross Margin (35.78%) than 77.14% of its industry peers.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
Industry RankSector Rank
OM 19.8%
PM (TTM) 12.82%
GM 35.78%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRBR is creating value.
Compared to 1 year ago, BRBR has less shares outstanding
The number of shares outstanding for BRBR has been increased compared to 5 years ago.
The debt/assets ratio for BRBR has been reduced compared to a year ago.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.61 indicates that BRBR is not in any danger for bankruptcy at the moment.
The Altman-Z score of BRBR (8.61) is better than 85.71% of its industry peers.
The Debt to FCF ratio of BRBR is 6.07, which is on the high side as it means it would take BRBR, 6.07 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 6.07, BRBR is doing good in the industry, outperforming 65.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.07
Altman-Z 8.61
ROIC/WACC5.26
WACC8.78%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

BRBR has a Current Ratio of 2.92. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.92, BRBR is doing good in the industry, outperforming 74.29% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that BRBR should not have too much problems paying its short term obligations.
The Quick ratio of BRBR (1.34) is better than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 1.34
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.52% over the past year.
BRBR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.29% yearly.
The Revenue has grown by 18.91% in the past year. This is quite good.
Measured over the past years, BRBR shows a quite strong growth in Revenue. The Revenue has been growing by 18.50% on average per year.
EPS 1Y (TTM)32.52%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%17.78%
Revenue 1Y (TTM)18.91%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%18.88%

3.2 Future

The Earnings Per Share is expected to grow by 14.28% on average over the next years. This is quite good.
BRBR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.94% yearly.
EPS Next Y16.05%
EPS Next 2Y15.47%
EPS Next 3Y15.6%
EPS Next 5Y14.28%
Revenue Next Year16.1%
Revenue Next 2Y13.55%
Revenue Next 3Y12.39%
Revenue Next 5Y9.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.56, the valuation of BRBR can be described as expensive.
BRBR's Price/Earnings ratio is in line with the industry average.
BRBR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.82.
BRBR is valuated rather expensively with a Price/Forward Earnings ratio of 23.97.
BRBR's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, BRBR is valued at the same level.
Industry RankSector Rank
PE 28.56
Fwd PE 23.97
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRBR.
BRBR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 49.86
EV/EBITDA 19.35
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of BRBR may justify a higher PE ratio.
A more expensive valuation may be justified as BRBR's earnings are expected to grow with 15.60% in the coming years.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y15.47%
EPS Next 3Y15.6%

0

5. Dividend

5.1 Amount

BRBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BELLRING BRANDS INC

NYSE:BRBR (5/23/2025, 9:16:40 PM)

After market: 61.68 0 (0%)

61.68

+1.05 (+1.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners98.12%
Inst Owner Change2.76%
Ins Owners1.49%
Ins Owner Change6.94%
Market Cap7.83B
Analysts81.67
Price Target86.44 (40.14%)
Short Float %2.41%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.06%
Min EPS beat(2)-0.84%
Max EPS beat(2)18.96%
EPS beat(4)3
Avg EPS beat(4)9.41%
Min EPS beat(4)-0.84%
Max EPS beat(4)19.07%
EPS beat(8)7
Avg EPS beat(8)10.43%
EPS beat(12)11
Avg EPS beat(12)10.25%
EPS beat(16)14
Avg EPS beat(16)13.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.52%
Max Revenue beat(2)-0.33%
Revenue beat(4)1
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.64%
Revenue beat(8)4
Avg Revenue beat(8)1.03%
Revenue beat(12)6
Avg Revenue beat(12)0.06%
Revenue beat(16)8
Avg Revenue beat(16)0.68%
PT rev (1m)-1.29%
PT rev (3m)-1.46%
EPS NQ rev (1m)-13.55%
EPS NQ rev (3m)-13.55%
EPS NY rev (1m)-2.26%
EPS NY rev (3m)-2.1%
Revenue NQ rev (1m)-7.33%
Revenue NQ rev (3m)-7.33%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 28.56
Fwd PE 23.97
P/S 3.57
P/FCF 49.86
P/OCF 48.87
P/B N/A
P/tB N/A
EV/EBITDA 19.35
EPS(TTM)2.16
EY3.5%
EPS(NY)2.57
Fwd EY4.17%
FCF(TTM)1.24
FCFY2.01%
OCF(TTM)1.26
OCFY2.05%
SpS17.26
BVpS-2
TBVpS-3.57
PEG (NY)1.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.66%
ROE N/A
ROCE 61.65%
ROIC 46.22%
ROICexc 48.14%
ROICexgc 68.26%
OM 19.8%
PM (TTM) 12.82%
GM 35.78%
FCFM 7.17%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score6
Asset Turnover2.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.07
Debt/EBITDA 2.11
Cap/Depr 17.3%
Cap/Sales 0.15%
Interest Coverage 250
Cash Conversion 35.42%
Profit Quality 55.91%
Current Ratio 2.92
Quick Ratio 1.34
Altman-Z 8.61
F-Score6
WACC8.78%
ROIC/WACC5.26
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%17.78%
EPS Next Y16.05%
EPS Next 2Y15.47%
EPS Next 3Y15.6%
EPS Next 5Y14.28%
Revenue 1Y (TTM)18.91%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%18.88%
Revenue Next Year16.1%
Revenue Next 2Y13.55%
Revenue Next 3Y12.39%
Revenue Next 5Y9.94%
EBIT growth 1Y36.47%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year24.08%
EBIT Next 3Y15.63%
EBIT Next 5Y12.72%
FCF growth 1Y598.22%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y576.37%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%